21 CFR § 211.89 Current Good Manufacturing Practice for Finished Pharmaceuticals

§ 211.89 Rejected components, drug product containers, and closures.

Current through Sep 8, 2026 · Read all of Part 211

Rejected components, drug product containers, and closures shall be identified and controlled under a quarantine system designed to prevent their use in manufacturing or processing operations for which they are unsuitable.

← § 211.87 Retesting of approved components, drug product containers, and closures.§ 211.94 Drug product containers and closures. →